247 related articles for article (PubMed ID: 26738368)
1. Echocardiographic Evaluation of the Relationship Between inflammatory factors (IL6, TNFα, hs-CRP) and Secondary Pulmonary Hypertension in patients with COPD. A Cross sectional study.
Ansarin K; Rashidi F; Namdar H; Ghaffari M; Sharifi A
Pneumologia; 2015; 64(3):31-5. PubMed ID: 26738368
[TBL] [Abstract][Full Text] [Related]
2. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
3. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?
Sarioglu N; Hismiogullari AA; Bilen C; Erel F
Rev Port Pneumol (2006); 2016; 22(1):11-7. PubMed ID: 26534740
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
[TBL] [Abstract][Full Text] [Related]
5. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Komnata K
Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
[TBL] [Abstract][Full Text] [Related]
6. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between inflammatory mediators and pulmonary hypertension in patients with chronic obstructive pulmonary disease].
Jiang YW; Pang L; Fang QH; Ma YM
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):904-8. PubMed ID: 22333502
[TBL] [Abstract][Full Text] [Related]
8. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease.
Seyhan EC; Özgül MA; Tutar N; Ömür I; Uysal A; Altin S
COPD; 2013 Aug; 10(4):416-24. PubMed ID: 23537076
[TBL] [Abstract][Full Text] [Related]
10. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
13. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
14. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
Gotsman I; Stabholz A; Planer D; Pugatsch T; Lapidus L; Novikov Y; Masrawa S; Soskolne A; Lotan C
Isr Med Assoc J; 2008 Jul; 10(7):494-8. PubMed ID: 18751625
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
16. Systemic inflammation, COPD, and pulmonary hypertension.
Hoeper MM; Welte T
Chest; 2007 Feb; 131(2):634-5; author reply 635. PubMed ID: 17296674
[No Abstract] [Full Text] [Related]
17. Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction.
López-Sánchez M; Muñoz-Esquerre M; Huertas D; Montes A; Molina-Molina M; Manresa F; Dorca J; Santos S
Clin Respir J; 2017 Nov; 11(6):859-866. PubMed ID: 26663885
[TBL] [Abstract][Full Text] [Related]
18. Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive pulmonary disease?
Telo S; Kırkıl G; Kuluöztürk M; Balin M; Deveci F
Clin Respir J; 2018 Apr; 12(4):1433-1438. PubMed ID: 28756635
[TBL] [Abstract][Full Text] [Related]
19. Correlation between hs-CRP, IL-6, IL-10, ET-1, and Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension.
Yang D; Wang L; Jiang P; Kang R; Xie Y
J Healthc Eng; 2022; 2022():3247807. PubMed ID: 35186226
[TBL] [Abstract][Full Text] [Related]
20. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
